The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion.

Autor: van Tongeren JMZ; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands., Harkes-Idzinga SF; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., van der Sijs H; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands., Atiqi R; Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands., van den Bemt BJF; Department of Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands.; Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands., Draijer LW; Huisartsenpraktijk Bij de Haven, Nijkerk, Netherlands., Hiel D; Department of Hospital Pharmacy, Alrijne Zorggroep, Leiden, Netherlands., Kerremans A; Independent Researcher, Helmond, Netherlands., Kremers B; Ravenstein apotheek, Ravenstein, Netherlands., de Leeuw M; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., Olthoff MV; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands., Pham TK; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands., Valentijn-Robertz R; De Vijverapotheek, Nieuwkoop, Netherlands., Tsoi K; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands., Wichers I; Department of Guideline Development and Research, Dutch College of General Practitioners, Utrecht, Netherlands., de Wit M; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., Borgsteede SD; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2020 May 15; Vol. 11, pp. 707. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.

Autor: Weersink RA; Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands. rianne.weersink@healthbase.nl.; Department of Pharmacy, Unit of Pharmacotherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands. rianne.weersink@healthbase.nl., Bouma M; Department of Guideline Development, Dutch College of General Practice, Utrecht, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands., Drenth JPH; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands., Harkes-Idzinga SF; Center for Information on Medicines, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., Hunfeld NGM; Department of Pharmacy and Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands., Metselaar HJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Monster-Simons MH; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands., Taxis K; Department of Pharmacy, Unit of Pharmacotherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands., Borgsteede SD; Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands.; SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands.

Publikováno v: Drug safety [Drug Saf] 2018 Jun; Vol. 41 (6), pp. 603-613.